Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOROURACIL Cause Product use issue? 178 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Product use issue have been filed in association with FLUOROURACIL (FLUOROURACIL). This represents 0.3% of all adverse event reports for FLUOROURACIL.

178
Reports of Product use issue with FLUOROURACIL
0.3%
of all FLUOROURACIL reports
30
Deaths
30
Hospitalizations

How Dangerous Is Product use issue From FLUOROURACIL?

Of the 178 reports, 30 (16.9%) resulted in death, 30 (16.9%) required hospitalization, and 2 (1.1%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOROURACIL. However, 178 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOROURACIL Cause?

Diarrhoea (5,373) Neutropenia (4,400) Nausea (3,757) Vomiting (2,836) Off label use (2,788) Neuropathy peripheral (2,605) Thrombocytopenia (2,426) Fatigue (2,421) Disease progression (2,377) Febrile neutropenia (2,230)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which FLUOROURACIL Alternatives Have Lower Product use issue Risk?

FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOROURACIL\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOXETINE FLUOROURACIL vs FLUOXETINE\FLUOXETINE

Related Pages

FLUOROURACIL Full Profile All Product use issue Reports All Drugs Causing Product use issue FLUOROURACIL Demographics